A Phase I, Single-Center, Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Effect of High-Fat and Low-Fat Meals on the Pharmacokinetics of FWD1802 in Chinese Healthy Subjects
Latest Information Update: 23 Mar 2026
At a glance
- Drugs FWD 1802 (Primary)
- Indications HER2 negative breast cancer
- Focus Pharmacokinetics
- Sponsors Forward Pharma
Most Recent Events
- 23 Mar 2026 New trial record